Ibis Reproductive Health, Cambridge, Massachusetts, USA.
Perspect Sex Reprod Health. 2023 Jun;55(2):104-112. doi: 10.1363/psrh.12223. Epub 2023 Apr 11.
Removing the prescription requirement and making oral contraceptive pills available over the counter (OTC) could increase contraceptive access in the United States. Despite current efforts to make a progestin-only pill (POP) available OTC, there are no qualitative data exploring the experiences of POP users and their perspectives on making POPs available OTC.
We conducted six online, asynchronous focus group discussions with 36 POP users between July and November 2020. We stratified focus group discussion placement based on three reasons for POP use: breastfeeding, having a contraindication to estrogen (for a reason other than breastfeeding), and for any other reason. We thematically analyzed these data using inductive and deductive coding.
The majority of participants described their overall POP experience as positive, mostly because they experienced minor or no side effects and thought the pill was effective. Participants overwhelmingly supported OTC availability of POPs and expressed interest in purchasing an OTC POP. Over one-third of participants had very limited knowledge or held inaccurate assumptions about POPs before they started using this method and many stressed the need to disseminate accurate information and resources about POPs to the public.
Most focus group discussion participants were satisfied with POPs and supported OTC access. While misconceptions and concerns about POPs should be addressed, an OTC POP has the potential to be a safe, effective, and convenient contraceptive option in the United States.
取消避孕药的处方要求并使口服避孕药(OC)能够在柜台(OTC)购买,可能会增加美国的避孕方法的可及性。尽管目前正在努力使孕激素仅避孕药(POP)能够在 OTC 购买,但没有定性数据探讨 POP 用户的经验及其对 OTC 购买 POP 的看法。
我们在 2020 年 7 月至 11 月期间,对 36 名 POP 用户进行了六次在线异步焦点小组讨论。我们根据使用 POP 的三个原因对焦点小组讨论进行了分层:母乳喂养、有雌激素禁忌(非母乳喂养原因)和其他任何原因。我们使用归纳和演绎编码对这些数据进行了主题分析。
大多数参与者描述了他们对 POP 的整体体验是积极的,主要是因为他们经历了轻微或没有副作用,并且认为该药物有效。参与者压倒性地支持 POP 的 OTC 可用性,并表示有兴趣购买 OTC POP。超过三分之一的参与者在开始使用这种方法之前对 POP 知之甚少或存在不准确的假设,许多人强调需要向公众传播有关 POP 的准确信息和资源。
大多数焦点小组讨论参与者对 POP 感到满意并支持 OTC 获得。虽然应该解决对 POP 的误解和担忧,但 OTC POP 在美国有可能成为一种安全、有效且方便的避孕选择。